CLINICAL_TRIALS
trial_result
· 2013-05-06
Clinical Trial Update: A Dose-Finding Study of Topiramate (JNS019) in Participants With Migraine [Phase 2]
Summary
Phase 2 dose-finding study of topiramate (JNS019) for migraine completed; results were posted in May 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutical K.K. | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2013-05-06